Sinaptica Therapeutics, Inc


Sinaptica Therapeutics is a pioneering company developing personalized, non-invasive neuromodulation therapies for Alzheimer's Disease and other neurodegenerative conditions. Their mission is to significantly slow disease progression through innovative brain stimulation techniques, leveraging advanced neuroimaging, AI, and machine learning to tailor treatments to individual patients. With a focus on safety, efficacy, and cost-effectiveness, Sinaptica aims to transform the landscape of neurodegenerative disease management and improve patient outcomes.

Industries

manufacturing
medical-device
therapeutics

Nr. of Employees

small (1-50)

Sinaptica Therapeutics, Inc

Cambridge, Massachusetts, United States, North America


Products

Investigational personalized neuromodulation platform

An investigational noninvasive neuromodulation platform that integrates MRI-guided neuronavigation, stimulation hardware and concurrent electrophysiology with cloud-based algorithms to deliver individualized stimulation to targeted brain networks using an induction-plus-maintenance protocol. Intended for investigational use in clinical research.


Services

Clinical development and execution of randomized neuromodulation trials

Design and conduct of randomized, double-blind, sham-controlled clinical studies of personalized noninvasive neuromodulation, including imaging and electrophysiology sub-studies, safety monitoring, and multi-center site coordination.

Imaging and electrophysiology analysis services

Structural, microstructural and connectivity MRI analyses and extraction of stimulation-evoked electrophysiology features to evaluate biological effects of neuromodulation interventions and support biomarker development.

Device co-development and manufacturing partnership facilitation

Facilitation of development and supply collaborations with specialized stimulation, neuronavigation and electrophysiology hardware manufacturers to support clinical system development, trial deployment and scale-up to commercial production.

Public-private partnership and stakeholder engagement facilitation

Support for establishing and managing public-private collaborations involving government, industry, academia, patient-advocacy and philanthropic organizations to advance research programs and consortia.

Integration and deployment of scalable secure research data platforms

Advisory and implementation services to build or integrate secure, scalable research workbench platforms and data infrastructure to support multi-site studies and large-scale analyses.

Expertise Areas

  • Neuromodulation clinical development and trial operations
  • Perturbation-based electrophysiology biomarker discovery (TMS-EEG)
  • Multimodal neuroimaging and connectomics analysis (structural, diffusion, functional MRI)
  • Machine learning for treatment personalization and longitudinal recalibration
  • Show More (9)

Key Technologies

  • Repetitive transcranial magnetic stimulation (rTMS)
  • MRI-guided neuronavigation
  • Concurrent stimulation and electrophysiology (TMS-EEG)
  • High-density multi-channel EEG
  • Show More (8)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.